Article Versions Notes

Adorni MP, Galetti M, La Monica S, Incerti M, Ruffoni A, Elviri L, Zanotti I, Papotti B, Cavallo D, Alfieri R, et al. A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC. International Journal of Molecular Sciences. 2023; 24(2):989. https://doi.org/10.3390/ijms24020989

Adorni, Maria Pia, Maricla Galetti, Silvia La Monica, Matteo Incerti, Alessandro Ruffoni, Lisa Elviri, Ilaria Zanotti, Bianca Papotti, Delia Cavallo, Roberta Alfieri, and et al. 2023. "A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC" International Journal of Molecular Sciences 24, no. 2: 989. https://doi.org/10.3390/ijms24020989

Adorni, M. P., Galetti, M., La Monica, S., Incerti, M., Ruffoni, A., Elviri, L., Zanotti, I., Papotti, B., Cavallo, D., Alfieri, R., Petronini, P. G., & Bernini, F. (2023). A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC. International Journal of Molecular Sciences, 24(2), 989. https://doi.org/10.3390/ijms24020989